Physiomics PLC Director Dealing (8427V)
12 Agosto 2020 - 1:00AM
UK Regulatory
TIDMPYC
RNS Number : 8427V
Physiomics PLC
12 August 2020
12 August 2020
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that it received notice today that Dr Jim
Millen sold 597,332 ordinary shares in the Company at 6.45p per
share to cover the cost of his exercise of options announced on 5
August 2020.
Following the sale of shares, the total holdings of Dr Jim
Millen will be 1,386,947, representing approximately 1.42 per cent.
of the Company's issued share capital.
The information contained within this announcement is deemed by
the Company to constitute inside information under the Market Abuse
Regulation (EU) No. 596/2014.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
Richard Tulloch & James Dance
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS
DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY
ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated
a) Name James Millen
--------------------------------------------------------------------- -------------------------
2 Reason for the notification
------------------------------------------------------------------------------------------------
a) Position/status Director, CEO
--------------------------------------------------------------------- -------------------------
b) Initial notification/ Amendment Initial notification
--------------------------------------------------------------------- -------------------------
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer
or auction monitor
------------------------------------------------------------------------------------------------
a) Name Physiomics plc
--------------------------------------------------------------------- -------------------------
b) LEI 213800A71DSZ6ABMTQ91
--------------------------------------------------------------------- -------------------------
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii)
each type of transaction; (iii) each date; and (iv) each place where transactions have been
conducted
------------------------------------------------------------------------------------------------
a) Description of the financial instrument, type of instrument Ordinary shares
Identification code
GB00BDR6W943
--------------------------------------------------------------------- -------------------------
b) Nature of the transaction Disposal of shares
--------------------------------------------------------------------- -------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
6.45p 597,332
----------
--------------------------------------------------------------------- -------------------------
d) Aggregated information
* Aggregated volume 597,332
At 6.45p per share
* Price
--------------------------------------------------------------------- -------------------------
e) Date of the transaction 11-8-2020
--------------------------------------------------------------------- -------------------------
f) Place of the transaction XLON, AIM
--------------------------------------------------------------------- -------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHPBMRTMTJBBFM
(END) Dow Jones Newswires
August 12, 2020 02:00 ET (06:00 GMT)
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Physiomics (LSE:PYC)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024
